Health In Tech, Inc. Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect
Health In Tech, Inc. (HIT) reported Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect of -$1.15 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Cash Flow
us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect · last filed 2026-08-13
- Health In Tech, Inc. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), excluding exchange rate effect for the quarter ending 2026-03-31 was $2.66M.
- Health In Tech, Inc. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), excluding exchange rate effect for the quarter ending 2025-03-31 was -$274.21K.
- Health In Tech, Inc. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), excluding exchange rate effect for the quarter ending 2024-03-31 was -$1.06M.
- Health In Tech, Inc. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), excluding exchange rate effect for fiscal 2025 was -$179.49K, a 103.30% decline from fiscal 2024.
- Health In Tech, Inc. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), excluding exchange rate effect for fiscal 2024 was $5.43M, a 485.19% increase from fiscal 2023.
- Health In Tech, Inc. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), excluding exchange rate effect for fiscal 2023 was $928.40K.
| Period end | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect 3 month | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect 6 month | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect 9 month | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$1.15M 10-Q · filed 2026-08-13 | |||
| 2026-03-31 | $2.66M 10-Q · filed 2026-05-14 | |||
| 2025-12-31 | -$179.49K 10-K · filed 2026-03-25 | |||
| 2025-09-30 | $174.37K 10-Q · filed 2025-11-12 | |||
| 2025-06-30 | $288.92K 10-Q · filed 2026-08-13 | |||
| 2025-03-31 | -$274.21K 10-Q · filed 2026-05-14 | |||
| 2024-12-31 | $5.43M 10-K · filed 2026-03-25 | |||
| 2024-09-30 | -$669.12K 10-Q · filed 2025-11-12 | |||
| 2024-06-30 | -$253.15K 10-Q · filed 2025-08-08 | |||
| 2024-03-31 | -$1.06M 10-Q · filed 2025-05-09 | |||
| 2023-12-31 | $928.40K 10-K · filed 2025-03-17 |